Clinical Trial

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2023 (before its estimated June 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
Trial Details
NCT Number NCT05745805
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Collaborators: Nuclear 215 Hospital of Shaanxi Province, Yanan Traditional Chinese Medicine Hospital, Shangluo Central Hospital, Xian QinHuang Hospital, Yulin No.2 Hospital, Hanzhong Central Hospital, Ankang Central Hospital, Baoji High-tech Hospital
Conditions COVID-19, Post-COVID-19 Syndrome, Acute COVID-19, Post-Acute COVID-19
Enrollment 600 participants
Start Date 2023-01-12
Primary Completion 2026-06-12 (estimated)
Study Completion 2026-09-12 (estimated)
Updated on ClinicalTrials.gov 2023-02-27